COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with COPD (a chronic lung condition), with this diagnosis recorded in their GP records for at least 12 months
- People aged 35 years or older
- People who have been prescribed prednisolone (a steroid medication) 3 or more times in the past 12 months for flare-ups of their COPD, where each course of prednisolone was at least 14 days apart
- People who are able to understand the study and agree to take part
- People who are in a stable state of health at the time of joining, meaning at least 4 weeks have passed since their last COPD flare-up or other serious illness
Who may not be able to join:
- People who are currently taking, or have taken in the past 12 months, oral steroids (such as prednisolone) every day as a regular ongoing treatment (defined as 10mg or more daily for 6 weeks or longer)
- People who, in the opinion of the trial team, are unlikely to be able to follow the study requirements
- People who have another illness (separate from COPD) that is expected to limit their life expectancy to less than 12 months
- People who are housebound and unable to leave their home
- People who have had a lung transplant
- People who use a breathing support machine (non-invasive ventilation) at home
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ruth E Sobala, MBBS, Northumbria Healthcare Foundation NHS Trust
Phone: +44191 293 4351
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cumulative dose of oral prednisolone over 12-months*. * excluding short courses of prednisolone prescribed for conditions not related to airway exacerbations (e.g. anaphylaxis, inflammatory bowel disease, cutaneous skin disorders).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.